Citigroup Inc Vapotherm Inc Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.44 - $13.52 $531 - $4,988	-369 Reduced 1.44%	25,242 $40,000
Q2 2022 Aug 10, 2022	SELL	$2.52 - $14.42 $2,391 - $13,684	-949 Reduced 3.57%	25,611 $65,000
Q1 2022 May 12, 2022	SELL	$12.69 - $20.72 $60,226 - $98,337	-4,746 Reduced 15.16%	26,560 $369,000
Q4 2021 Feb 10, 2022	BUY	$19.7 - $23.71 $62,350 - $75,042	3,165 Added 11.25%	31,306 $649,000
Q3 2021 Nov 10, 2021	BUY	$21.32 - $29.36 $599,966 - $826,219	28,141 New	28,141 $627,000

1.35M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.